2009 PhRMA Code Certification

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Enzon Pharmaceuticals Inc.'s financial performance into perspective.

Print

2009 PhRMA Code Certification

2009 PhRMA Code Certification
Search
(ENZN) NASDAQ
Last Trade9.82
Change(%)price+0.01
Volume276901
News
  • 09-10-2009

    Enzon to Present at NewsMakers...

    Enzon to Present at NewsMakers in the Biotech Industry Conference

    click here for more information

  • 07-27-2009

    Enzon to Release Second Quarte...

    Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow

    click here for more information

  • 07-27-2009

    Enzon to Present at BMO Focus...

    Enzon to Present at BMO Focus on Healthcare Conference

    click here for more information

  • 07-23-2009

    Enzon Enhances Governance with...

    Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

    click here for more information

  • 09-10-2009

    Enzon to Present at NewsMakers...

    Enzon to Present at NewsMakers in the Biotech Industry Conference

    click here for more information

  • 05-06-2009

    Enzon Reaches Phase II Dose fo...

    Enzon Reaches Phase II Dose for PEG-SN38
    -- Composition of matter patent granted until 2027--

    click here for more information

  • 04-23-2008

    Cimzia®, Utilizing Enzon's PE...

    Cimzia®, Utilizing Enzon's PEGylation Technology, Approved in the U.S.

    click here for more information

  • 07-29-2008

    Enzon to Release Second Quarte...

    Enzon to Release Second Quarter 2008 Earnings on Wednesday, August 6, 2008; Conference Call and Webcast to Follow

    click here for more information

  • 03-19-2009

    Enzon Reveals New LNA Targets<...

    Enzon Reveals New LNA Targets
    -- Data will be presented at upcoming American Association for Cancer Research Meeting--

    click here for more information

  • 09-30-2008

    Enzon's New Oncaspar-IV™ Rec...

    Enzon's New Oncaspar-IV™ Receives Orphan Drug Status in the EU
    -- Improved version to expand global potential --

    click here for more information

  • 05-28-2008

    Jack Geltosky, Ph.D. Joins Enz...

    Jack Geltosky, Ph.D. Joins Enzon's Board of Directors

    click here for more information

  • 12-08-2008

    Enzon Pharmaceuticals Commence...

    Enzon Pharmaceuticals Commences Tender Offer For a Portion of its Debt

    click here for more information